Litcius/Paper detail

Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer

Raquibul Hannan, Mark F. McLaughlin, Laurentiu M. Pop, Iván Pedrosa, Payal Kapur, Aurélie Garant, Chul Ahn, Alana Christie, James Zhu, Tao Wang, Liliana Robles, Deniz Durakoglugil, Solomon L. Woldu, Vitaly Margulis, Jeffrey Gahan, James Brugarolas, Robert Timmerman, Jeffrey A. Cadeddu

2023European Urology60 citationsDOIOpen Access PDF

Topics & Concepts

MedicineSABR volatility modelInterquartile rangeClinical endpointClear cellUrologyBiopsyRenal cell carcinomaInterim analysisResponse Evaluation Criteria in Solid TumorsClear cell renal cell carcinomaRadiologyInternal medicinePhases of clinical researchRandomized controlled trialChemotherapyVolatility (finance)Stochastic volatilityEconomicsFinancial economicsRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsCutaneous Melanoma Detection and Management
Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer | Litcius